Top

Virology Journal

Published in:

Open Access 01-12-2010 | Research

Genetic characterization of the cell-adapted PanAsia strain of foot-and-mouth disease virus O/Fujian/CHA/5/99 isolated from swine

Authors: XingWen Bai, HuiFang Bao, PingHua Li, Pu Sun, WenDong Kuang, YiMei Cao, ZengJun Lu, ZaiXin Liu, XiangTao Liu

Published in: Virology Journal | Issue 1/2010

Abstract

Background

According to Office International Des Epizooties (OIE) Bulletin, the PanAsia strain of Foot-and-Mouth Disease Virus (FMDV) was invaded into the People's Republic of China in May 1999. It was confirmed that the outbreaks occurred in Tibet, Hainan and Fujian provinces. In total, 1280 susceptible animals (68 cattle, 1212 swine) were destroyed for the epidemic control.

To investigate the distinct biological properties, we performed plaque assay, estimated the pathogenicity in suckling mice and determined the complete genomic sequence of FMDV swine-isolated O/Fujian/CHA/5/99 strain. In addition, a molecular modeling was carried out with the external capsid proteins.

Results

The pathogenicity study showed that O/Fujian/CHA/5/99 had high virulence with respect to infection in 3-day-old suckling-mice (LD₅₀ = 10^-8.3), compared to O/Tibet/CHA/1/99 (LD50 = 10^-7.0) which isolated from bovine. The plaque assay was distinguishable between O/Fujian/CHA/5/99 and O/Tibet/CHA/1/99 by their plaque phenotypes. O/Fujian/CHA/5/99 formed large plaque while O/Tibet/CHA/1/99 formed small plaque.

The 8,172 nucleotides (nt) of O/Fujian/CHA/5/99 was sequenced, and a phylogenetic tree was generated from the complete nucleotide sequences of VP1 compared with other FMDV reference strains. The identity data showed that O/Fujian/CHA/5/99 is closely related to O/AS/SKR/2002 (94.1% similarity). Based on multiple sequence alignments, comparison of sequences showed that the characteristic nucleotide/amino acid mutations were found in the whole genome of O/Fujian/CHA/5/99.

Conclusion

Our finding suggested that C275T substitution in IRES of O/Fujian/CHA/5/99 may induce the stability of domain 3 for the whole element function. The structure prediction indicated that most of 14 amino acid substitutions are fixed in the capsid of O/Fujian/CHA/5/99 around B-C loop and E-F loop of VP2 (antigenic site 2), and G-H loop of VP1 (antigenic site 1), respectively. These results implicated that these substitutions close to heparin binding sites (E136G in VP2, A174 S in VP3) and at antigenic site 1 (T142A, A152T and Q153P in VP1) may influence plaque size and the pathogenicity to suckling mice.

The potential of genetic characterization would be useful for microevolution and viral pathogenesis of FMDV in the further study.

Available only for authorised users

Pereira HG: Subtyping of foot-and-mouth disease virus. Dev Biol Stand 1977, 35: 167-174.

Beck E, Strohmaier K: Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol 1987, 61: 1621-1629.PubMedPubMedCentral

Knowles NJ, Samuel AR: Molecular epidemiology of foot-and-mouth disease virus. Virus Res 2003, 91: 65-80. 10.1016/S0168-1702(02)00260-5PubMedCrossRef

Mason PW, Grubman MJ, Baxt B: Molecular basis of pathogenesis of FMDV. Virus Res 2003, 91: 9-32. 10.1016/S0168-1702(02)00257-5PubMedCrossRef

Sangar DV, Rowlands DJ, Harris TJR, Brown F: A protein covalently linked to foot-and-mouth disease virus RNA. Nature 1977, 268: 648-650. 10.1038/268648a0PubMedCrossRef

Ryan MD, Belsham GJ, King AMQ: Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology 1989, 173: 35-45. 10.1016/0042-6822(89)90219-5PubMedCrossRef

Porter AG: Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. J Virol 1993, 67: 6917-6921.PubMedPubMedCentral

Belsham GJ, Martínez-Salas E: Genome organisation, translation and replication of foot-and-mouth disease virus RNA. In Foot-and-Mouth Disease: Current Perspectives. Edited by: Sobrino F, Domingo E. London: Horizon Scientific Press; 2004:19-52.

Gutiérrez A, Martínez-Salas E, Pintado B, Sobrino F: Specific inhibition of aphthovirus infection by RNAs transcribed from both the 5' and the 3' noncoding regions. J Virol 1994, 68: 7426-7432.PubMedPubMedCentral

10.

Agol VI, Paul AV, Wimmer E: Paradoxes of the replication of picornaviral genomes. Virus Res 1999, 62: 129-147. 10.1016/S0168-1702(99)00037-4PubMedCrossRef

11.

Sakamoto K, Yoshida K: Recent outbreaks of foot and mouth disease in countries of east Asia. Rev sci tech Off int Epiz 2002, 21: 459-463.

12.

Dunn CS, Donaldson AI: Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus. Vet Rec 1997, 141: 174-175. 10.1136/vr.141.7.174PubMedCrossRef

13.

Beard CW, Mason PW: Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol 2000, 74: 987-991. 10.1128/JVI.74.2.987-991.2000PubMedPubMedCentralCrossRef

14.

Knowles NJ, Davies PR, Henry T, O'Donnell V, Pacheco JM, Mason PW: Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein. J Virol 2001, 75: 1551-1556. 10.1128/JVI.75.3.1551-1556.2001PubMedPubMedCentralCrossRef

15.

Ome JK, Yeh MT, McKenna TS, Hayes JR, Rieder E, Guiffre AC, Robida JM, Lee KN, Cho IS, Fang X, Yoo YS, Park JH: Pathogenic characteristics of the Korean 2002 isolate of foot-and-mouth disease virus serotype O in pigs and cattle. J Comp Pathol 2008, 138: 204-214. 10.1016/j.jcpa.2008.01.007CrossRef

16.

Sakamoto K, Yamakawa M, Kanno T, Yoshida K: Susceptibility and pathogenicity of cloven-hoofed animals inoculated with foot-and-mouth disease virus O/JPN/2000 isolate. Office International des Epizooties, Report of the Second OIE Meeting of Foot and Mouth Disease Control in East Asia. Korea: Seoul 2001, 3-8. (Appendix)

17.

Kanno T, Yamakawa M, Yoshida K, Sakamoto K: The complete nucleotide sequence of the PanAsia strain of foot-and-mouth disease virus isolated in Japan. Virus Genes 2002, 25: 119-125. 10.1023/A:1020103700108PubMedCrossRef

18.

Morioka K, Fukai K, Ohashi S, Sakamoto K, Tsuda T, Yoshida K: Comparison of the characters of the plaque-purified viruses from foot-and-mouth disease virus O/JPN/2000. J Vet Med Sci 2008, 70: 653-658. 10.1292/jvms.70.653PubMedCrossRef

19.

Zhang XS, Liu ZX, Zhao QZ, Chang HY, Xie QG: Sequencing and analysis for the full-length genome RNA of foot-and-mouth disease virus China/99. Sci China Ser C Life Sci 2004, 47: 74-81. 10.1360/02yc0169CrossRef

20.

Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL: Comparative genomics of foot-and-mouth disease virus. J Virol 2005, 79: 6487-6504. 10.1128/JVI.79.10.6487-6504.2005PubMedPubMedCentralCrossRef

21.

Martínez-Salas E, Regalado MP, Domingo E: Identification of an essential region for internal initiation of translation in the aphthovirus internal ribosome entry site and implications for viral evolution. J Virol 1996, 70: 992-998.PubMedPubMedCentral

22.

Strebel K, Beck E: A second protease of foot-and-mouth disease virus. J Virol 1986, 58: 893-899.PubMedPubMedCentral

23.

Glaser W, Cencic R, Skern T: Foot-and-mouth disease virus leader proteinase: involvement of C-terminal residues in self-processing and cleavage of eIF4GI. J Biol Chem 2001, 276: 35473-35481. 10.1074/jbc.M104192200PubMedCrossRef

24.

Piccone ME, Zellner M, Kumosinski TF, Mason PW, Grubman MJ: Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J Virol 1995, 69: 4950-4956.PubMedPubMedCentral

25.

Roberts PJ, Belsham GJ: Identification of critical amino acids within the foot-and-mouth disease virus Leader protein, a cysteine protease. Virology 1995, 213: 140-146. 10.1006/viro.1995.1554PubMedCrossRef

26.

Brown CC, Piccone ME, Mason PW, McKenna TSC, Grubman MJ: Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol 1996, 70: 5638-5641.PubMedPubMedCentral

27.

Mateu MG, Hernández J, Martínez MA, Feigelstock D, Lea S, Pérez JJ, Giralt E, Stuart D, Palma EL, Domingo E: Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol 1994, 68: 1407-1417.PubMedPubMedCentral

28.

Baranowski E, Sevilla N, Verdaguer N, Ruiz-Jarabo CM, Beck E, Domingo E: Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol 1998, 72: 6362-6372.PubMedPubMedCentral

29.

Hemadri D, Tosh C, Sanyal A, Venkataramanan R: Emergence of a new strain of type O foot-and-mouth disease virus: its phylogenetic and evolutionary relationship with the PanAsia pandemic strain. Virus Genes 2002, 25: 23-24. 10.1023/A:1020165923805PubMedCrossRef

30.

Kitching RP: Global epidemiology and prospects for control of foot-and-mouth disease. Curr Top Microbiol Immunol 2005, 288: 133-148. full_textPubMed

31.

Knowles NJ, Samuel AR, Davies PR, Midgley RJ, Valarcher JF: Pandemic strain of foot-and-mouth disease virus serotype O. Emerg Infect Dis 2005, 11: 1887-1893.PubMedPubMedCentralCrossRef

32.

Knowles NJ, Samuel AR, Davies PR, Kitching RP, Donaldson AI: Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet Rec 2001, 148: 258-259.PubMed

33.

Huang CC, Lin YL, Huang TS, Tu WJ, Lee SH, Jong MH, Lin SY: Molecular characterization of foot-and-mouth disease virus isolated from ruminants in Taiwan in 1999-2000. Vet Microbiol 2001, 81: 193-205. 10.1016/S0378-1135(01)00308-XPubMedCrossRef

34.

Gamarnik AV, Andino R: Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev 1998, 12: 2293-2304. 10.1101/gad.12.15.2293PubMedPubMedCentralCrossRef

35.

Mason PW, Bezborodova SV, Henry TM: Identification of characterization of a cis -acting replication element ( cre ) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J Virol 2002, 76: 9686-9694. 10.1128/JVI.76.19.9686-9694.2002PubMedPubMedCentralCrossRef

36.

George M, Venkataramanan R, Gurumurthy CB, Hemadri D: The non-structural leader protein gene of foot-and-mouth disease virus is highly variable between serotypes. Virus Genes 2001, 22: 271-278. 10.1023/A:1011153904910PubMedCrossRef

37.

Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW: Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 1997, 71: 5115-5123.PubMedPubMedCentral

38.

Jackson T, Ellard FM, Abu-Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996, 70: 5282-5287.PubMedPubMedCentral

39.

Jackson T, King AM, Stuart DI, Fry E: Structure and receptor binding. Virus Res 2003, 91: 33-46. 10.1016/S0168-1702(02)00258-7PubMedCrossRef

40.

Núñez JI, Baranowski E, Molina N, Ruiz-Jarabo CM, Sánchez C, Domingo E, Sobrino F: A single amino acid substitution in non-structural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol 2001, 75: 3977-3983. 10.1128/JVI.75.8.3977-3983.2001PubMedPubMedCentralCrossRef

41.

Graff J, Kasang C, Normann A, Pfisterer-Hunt M, Feinstone SM, Flehmig B: Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation. Virology 1994, 204: 60-68. 10.1006/viro.1994.1510PubMedCrossRef

42.

Heinz BA, Vance LM: Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses. J Virol 1996, 70: 4854-4857.PubMedPubMedCentral

43.

Lama J, Sanz MA, Carrosco L: Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J Gen Virol 1998, 79: 1911-1921.PubMedCrossRef

44.

Giraudo AT, Beck E, Strebel K, de Mello PA, La Torre JL, Scodeller EA, Bergmann IE: Identification of a nucleotide deletion in parts of polypeptide 3A in two independent attenuated aphthovirus strains. Virology 1990, 177: 780-783. 10.1016/0042-6822(90)90549-7PubMedCrossRef

45.

Arias A, Agudo R, Ferrer-Orta C, Pérez-Luque R, Airaksinen A, Brocchi E, Domingo E, Verdaguer N, Escarmís C: Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. J Mol Biol 2005, 353: 1021-1032. 10.1016/j.jmb.2005.09.022PubMedCrossRef

46.

Liu GQ, Liu ZX, Xie QG, Chen YL, Bao HF, Chang HY, Liu XT: Generation of an infectious cDNA clone of an FMDV strain isolated from swine. Virus Res 2004, 104: 157-164. 10.1016/j.virusres.2004.04.002PubMedCrossRef

47.

Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27: 493-497.

48.

Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F: The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 1989, 337: 709-716. 10.1038/337709a0PubMedCrossRef

49.

Parry N, Fox G, Rowlands D, Brwon F, Fry E, Acharya R, Logan D, Stuart D: Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 1990, 347: 569-572. 10.1038/347569a0PubMedCrossRef

50.

Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, Lea S, Lewis R, Newman J, Parry N, Rowlands D, Stuart D, Fry E: Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993, 362: 566-568. 10.1038/362566a0PubMedCrossRef

51.

Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI: The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 1999, 18: 543-554. 10.1093/emboj/18.3.543PubMedPubMedCentralCrossRef

52.

Lea S, Hernández J, Blakemore W, Brocchi E, Curry S, Domingo E, Fry E, Abu-Ghazaleh R, King A, Newman J, Stuart D, Mateu MG: The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 1994, 2: 123-139. 10.1016/S0969-2126(00)00014-9PubMedCrossRef

53.

Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Rowlands D, Stuart D: Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 1996, 4: 135-145. 10.1016/S0969-2126(96)00017-2PubMedCrossRef

Title: Genetic characterization of the cell-adapted PanAsia strain of foot-and-mouth disease virus O/Fujian/CHA/5/99 isolated from swine
Authors: XingWen Bai
HuiFang Bao
PingHua Li
Pu Sun
WenDong Kuang
YiMei Cao
ZengJun Lu
ZaiXin Liu
XiangTao Liu
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/1743-422X-7-208

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Genetic characterization of the cell-adapted PanAsia strain of foot-and-mouth disease virus O/Fujian/CHA/5/99 isolated from swine

Abstract

Background

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2010

Detection of poliovirus by ICC/qPCR in concentrated water samples has greater sensitivity and is less costly using BGM cells in suspension as compared to monolayers

Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor

Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses

A simple and rapid method for detection of Goose Parvovirus in the field by loop-mediated isothermal amplification

Hepatitis B virus genotypes and precore and core mutants in UAE patients

A role for the histone deacetylase HDAC4 in the life-cycle of HIV-1-based vectors

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page